{"id":61240,"date":"2025-05-12T19:02:16","date_gmt":"2025-05-12T17:02:16","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/global-healthy-living-foundation-takes-national-340b-reform-and-transparency-briefing-to-new-york\/"},"modified":"2025-05-12T19:02:16","modified_gmt":"2025-05-12T17:02:16","slug":"global-healthy-living-foundation-takes-national-340b-reform-and-transparency-briefing-to-new-york","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/global-healthy-living-foundation-takes-national-340b-reform-and-transparency-briefing-to-new-york\/","title":{"rendered":"Global Healthy Living Foundation Takes National 340B Reform and Transparency Briefing To New York"},"content":{"rendered":"
\n

\nChief Legal and Policy Officer, Steven Newmark, Joins Policy Briefing with Assemblymember Amanda Septimo and the Community Liver Alliance<\/b>\n<\/p>\n

UPPER NYACK, N.Y.–(BUSINESS WIRE)–Steven Newmark, Chief Legal and Policy Officer of the Global Healthy Living Foundation (GHLF), takes the organization\u2019s national 340B reform message to a policy briefing in Albany, NY, on May 13, addressing the national implications of unchecked expansion of the federal 340B Drug Pricing Program \u2014 a critical but increasingly controversial tool designed to support healthcare access for underserved populations.\n<\/p>\n

<\/a>
<\/a><\/p>\n

\nNewmark will join lawmakers, academic experts, and fellow advocates to urge greater transparency and accountability in how hospitals and other healthcare institutions use the steep drug discounts they receive under 340B. While originally intended to help vulnerable patients afford essential medications, the program has come under scrutiny for allowing covered entities to pocket savings without passing them along to patients.\n<\/p>\n

\n\u201cThe 340B program is a lifeline when it works as intended \u2014 but without oversight, it risks becoming a loophole instead of a safety net,\u201d said Newmark. \u201cWe need reform before expansion. Patients, not institutions, should be the primary beneficiaries.\u201d\n<\/p>\n

\nAs it has in other states, GHLF, a national nonprofit that advocates for people living with chronic illness, is raising concerns about proposed legislation in New York (S.1913 \/ A.7789) that would make it easier to expand 340B eligibility to additional entities without requiring clear patient benefit or public accountability. The Foundation has issued a memorandum in opposition, warning that such policies may incentivize profit-seeking behavior at the expense of patient care \u2014 a trend already observed across multiple states.\n<\/p>\n

\nThe May 13 policy forum, co-hosted by Assemblymember Amanda Septimo and the Community Liver Alliance, comes amid growing national debate about the future of 340B. Lawmakers in Congress have also introduced bills to audit and modernize the program, reflecting a bipartisan understanding that reform is needed to preserve the program\u2019s original mission.\n<\/p>\n

\nWhy It Matters Nationally\n<\/p>\n